Strategic Partnerships Lunaphore's active collaborations with industry leaders such as Discovery Life Sciences, Nikon, and Cell Signaling Technology highlight opportunities to expand into integrated spatial biology solutions and co-marketing initiatives, demonstrating strong market interest and validation.

Recent Product Launches The company's launch of the same-section hyperplex multiomics application indicates a growing demand for advanced, automated multiplex assays, opening avenues for sales of complementary reagents, automation tools, and related services.

Market Expansion With recent partnerships in the US and globally, there is potential to upsell platform upgrades, additional assay kits, and laboratory support services to existing customers and new regional markets seeking innovative spatial biology capabilities.

Funding & Growth While currently generating modest revenue, Lunaphore’s $33 million in funding presents opportunities to invest in sales channels, customer training, and device deployment, accelerating adoption of their technology in research and clinical labs.

Industry Positioning Positioned among specialized biotech firms with a focus on spatial proteomics and genomics, Lunaphore can target biotech, pharma, and academic institutions seeking cutting-edge solutions, emphasizing integrated platform offerings and antibody supply collaborations for enhanced sales prospects.